Are RhythmOne plc, Dechra Pharmaceuticals plc and Pagegroup plc ‘buys’ after today’s updates?

Should you pile-in to these three stocks right now? RhythmOne plc (LON: RTHM), Dechra Pharmaceuticals plc (LON: DPH) and Pagegroup plc (LON: PAGE).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today’s update from Pagegroup (LSE: PAGE) shows that the global recruitment company endured a somewhat mixed Q2. While its performance in southern Europe and Benelux was impressive with gross profit growth of 25% and 30% respectively, elsewhere it struggled to deliver positive growth.

For example, in the UK Pagegroup’s gross profit fell by 2.3%, affected by pre-referendum uncertainty. Similarly, Asia Pacific saw a fall of 3.3% and the Americas also recorded a decline of 1.1%. However, this wasn’t enough to cause a decline in Pagegroup’s overall gross profit, with it rising by 3.7% versus the same period last year.

Looking ahead, Pagegroup is forecast to report a fall in earnings of 2% this year, followed by a further decline of 7% next year. This could hurt investor sentiment and with Pagegroup trading on a price-to-earnings (P/E) ratio of 15.2, its shares could continue to come under pressure following their 35% fall since the start of the year.

Good time to buy?

Also reporting today was Dechra Pharmaceuticals (LSE: DPH). Its trading in the most recent full year was strong, with revenue rising by 21%. It was aided by acquisitions, but even when they were excluded, Dechra’s top line still increased by 11%.

Encouragingly, the mood around Dechra’s North American business has been upbeat. Revenue rose by 37% versus the same period of last year, while the integration of the company’s three acquisitions has been in line with its expectations. This provides Dechra with a stronger platform for future growth and with the pharmaceutical company having an excellent pipeline of new treatments, its long-term future seems bright.

With Dechra trading on a P/E ratio of 29.5, many investors may see it as being grossly overpriced. After all, the FTSE 100 has a rating of about half that of Dechra’s. However, with Dechra forecast to increase its earnings by 20% next year, it appears to offer growth at a reasonable price. For example, it has a price-to-earnings growth (PEG) ratio of just 1.5, which indicates that now could be a good time to buy it.

Wait and see

Meanwhile, RhythmOne (LSE: RTHM) also released an update today, with the company formerly known as Blinkx seeing a share price rise of 16%. The key reason for this is RhythmOne expecting Q1 2017 performance to exceed previous expectations, based on preliminary results.

This was due to programmatic platform volumes more than tripling year-on-year, with over 1trn requests processed per month in the period. Furthermore, there were notable improvements in both fill rate and pricing, as mobile now represents the majority of volumes processed. And with core products continuing to ramp up during the period, RhythmOne’s future appears to be rather bright.

With RhythmOne due to remain lossmaking over the next two years, however, it may be prudent to await more news on the company’s financial performance before buying. Certainly, today’s news is positive, but it concerns a relatively short time period and so should be viewed cautiously.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »